Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
What you need to know about credit card rewards and taxes can save you money. Equip yourself with essential tips for smart financial management.
28,655 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
A two-year income lookback determines Medicare premiums for next year, catching early IRA inheritors by surprise and ...
Investors are abuzz about SpaceX's IPO, but two alarming statistics could quietly derail returns. This guide breaks d...
In 2026, AMD has taken the lead in the chip market while Nvidia hasn’t kept pace. This piece breaks down why, what co...
Traders are chasing the best stocks trade opportunities in a volatile February session. The focus is on highly liquid...
A wave of exits from startup builders of large language models is shrinking the field while giants pull further ahead...
An insider move of 8,000 shares can raise questions for investors. This article breaks down what such a sale might si...
A striking market move has analysts buzzing: the stock market just flashed a rare bullish signal. This article breaks...
As markets heat up this summer, here's this tech stock stands out for its AI-focused growth story, solid finances, an...
A straightforward, low-cost Vanguard strategy could outpace the S&P 500 in 2026. This guide explains why and shows co...
During a broad AI stock drawdown, Cathie Wood doubling down on CoreWeave signals a high-conviction bet. This article ...
As Okta gears up for 2027 earnings, investors weigh big growth bets against profitability hurdles. This guide breaks ...